In vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant system

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 1, 2010, Pages 191-197

  Kim, Jinku ^a   Dadsetan, Mahrokh ^a   Ameenuddin, Syed ^a   Windebank, Anthony J ^a   Yaszemski, Michael J ^a   Lu, Lichun ^a  

^a Mayo Clinic   (United States)

Author keywords

Cage implantation; Hydrogel; In vivo biocompatibility; In vivo biodegradation; PEG sebacic acid diacrylate (PEGSDA); RGD modified hydrogel

Indexed keywords

ARG GLY ASPS; CAGE IMPLANT; CAGE IMPLANTATION; CAGE SYSTEMS; CHRONIC INFLAMMATORY; CONTROL MATERIALS; DEGRADATION PRODUCTS; EMPTY-CAGE; FIBROUS CAPSULE; IN-VIVO; INFLAMMATORY RESPONSE; PLGA SCAFFOLDS; POLY-LACTIDE-CO-GLYCOLIDE; RGD PEPTIDE; RGD-MODIFIED HYDROGEL; SEBACIC ACID; STATISTICAL DIFFERENCES; STATISTICALLY SIGNIFICANT DIFFERENCE; WEIGHT LOSS;

ACIDS; BIOCOMPATIBILITY; BIODEGRADATION; DEGRADATION; HISTOLOGY; MICROBIOLOGY; PEPTIDES;

HYDROGELS;

ARGINYLGLYCYLASPARTIC ACID; MACROGOL; POLYGLACTIN; SEBACIC ACID; BIOMATERIAL; CD45 ANTIGEN; CD68 ANTIGEN, HUMAN; DECANOIC ACID DERIVATIVE; DICARBOXYLIC ACID; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MACROGOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CELL FUNCTION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HYDROGEL; IMPLANTATION; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PROTEIN MODIFICATION; RAT; TISSUE REGENERATION; WEIGHT REDUCTION; CHRONIC INFLAMMATION; EXUDATE; LEUKOCYTE COUNT; WEIGHT; ANIMAL; CHEMISTRY; DRUG EFFECT; MATERIALS TESTING; METABOLISM; METHODOLOGY; PATHOLOGY; PROSTHESES AND ORTHOSES; SPRAGUE DAWLEY RAT; SUBCUTANEOUS TISSUE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOCOMPATIBLE MATERIALS; DECANOIC ACIDS; DICARBOXYLIC ACIDS; EXUDATES AND TRANSUDATES; FEMALE; HYDROGELS; INFLAMMATION; LEUKOCYTE COUNT; MATERIALS TESTING; POLYETHYLENE GLYCOLS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; SUBCUTANEOUS TISSUE;

EID: 77956476202     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32810     Document Type: Article

References (23)

1. Shin H, Quinten Ruhe P, Mikos AG, Jansen JA. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly (ethylene glycol) fumarate) hydrogels. Biomaterials 2003;24:3201-3211.
2. Salthouse TN, Matlaga BF. Enzyme Histochemistry of the Cellular Response to Implants. Boca Raton: CRC Press; 1981. p 233-257.
3. Marchant R, Hiltner A, Hamlin C, Rabinovitch A, Slobodkin R, Anderson JM. In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel. J Biomed Mater Res 1983;17:301-325.
4. Dadsetan M, Christenson EM, Unger F, Ausborn M, Kissel T, Hiltner A, Anderson JM. In vivo biocompatibility and biodegradation of poly(ethylene carbonate). J Control Release 2003;93:259-270.
5. Kao WJ, Hiltner A, Anderson JM, Lodoen GA. Theoretical analysis of in vivo macrophage adhesion and foreign body giant cell formation on strained poly(etherurethane urea) elastomers. J Biomed Mater Res 1994;28:819-829. (Pubitemid 24184823)
6. Ronneberger B, Kao WJ, Anderson JM, Kissel T. In vivo biocompatibility study of ABA triblock copolymers consisting of poly (L-lactic-co-glycolic acid) A blocks attached to central poly (oxyethylene) B blocks. J Biomed Mater Res 1996;30:31-40.
7. Hubbell JA. Biomaterials in tissue engineering. Biotechnology 1995;13:565-576.
8. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;54:3-12.
9. Kim J, Lee KW, Hefferan TE, Currier BL, Yaszemski MJ, Lu L. Synthesis and evaluation of novel biodegradable hydrogels based on poly(ethylene glycol) and sebacic acid as tissue engineering scaffolds. Biomacromolecules 2008;9:149-157. (Pubitemid 351201593)
10. Hern DL, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998;39:266-276.
11. Shin H, Jo S, Mikos AG. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethylene glycol) spacer. J Biomed Mater Res A 2002;61:169-179.
12. Christenson EM, Dadsetan M, Hiltner A. Biostability and macrophage-mediated foreign body reaction of silicone-modified polyurethanes. J Biomed Mater Res A 2005;74:141-155.
13. Lu L, Peter SJ, Lyman MD, Lai HL, Leite SM, Tamada JA, Uyama S, Vacanti JP, Langer R, Mikos AG. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials 2000;21:1837-1845.
14. Wang DA, Williams CG, Li QA, Sharma B, Elisseeff JH. Synthesis and characterization of a novel degradable phosphate-containing hydrogel. Biomaterials 2003;24:3969-3980.
15. Wang YD, Ameer GA, Sheppard BJ, Langer R. A tough biodegradable elastomer. Nat Biotechnol 2002;20:602-606.
16. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 2004;428:487-492.
17. Ratner BD, Bryant SJ. Biomaterials: Where we have been and where we are going. Annu Rev Biomed Eng 2004;6:41-75. (Pubitemid 39209492)
18. Harris JM. Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications. New York: Plenum press; 1992.
19. Marchant R, Hiltner A, Hamlin C, Rabinovitch A, Slobodkin R, Anderson JM. In vivo biocompatibility studies. 1. The cage implant system and a biodegradable hydrogel. J Biomed Mater Res 1983;17:301-325.
20. Horbett TA, Brash JL, American Chemical Society. Division of colloid and surface chemistry. Meeting. Proteins at Interfaces II: Fundamentals and Applications. Washington, DC: American Chemical Society; 1995. xiv, 561 p.
21. Hynes RO. Integrins: A family of cell-surface receptors. Cell 1987;48:549-554.
22. Shin H, Ruhe PQ, Mikos AG, Jansen JA. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials 2003;24:3201-3211.
23. Ratner BD. Biomaterials Science: An Introduction to Materials in Medicine. Amsterdam, Boston: Elsevier Academic Press; 2004. xii, 851 p.